Clonal selection drives genetic divergence of metastatic medulloblastoma-Reference-Cited by-同舟云学术

Clonal selection drives genetic divergence of metastatic medulloblastoma

Published:2012-02 Issue:7386 Volume:482 Page:529-533
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Wu Xiaochong,Northcott Paul A.,Dubuc Adrian,Dupuy Adam J.,Shih David J. H.,Witt Hendrik,Croul Sidney,Bouffet Eric,Fults Daniel W.,Eberhart Charles G.,Garzia Livia,Van Meter Timothy,Zagzag David,Jabado Nada,Schwartzentruber Jeremy,Majewski Jacek,Scheetz Todd E.,Pfister Stefan M.,Korshunov Andrey,Li Xiao-Nan,Scherer Stephen W.,Cho Yoon-Jae,Akagi Keiko,MacDonald Tobey J.,Koster Jan,McCabe Martin G.,Sarver Aaron L.,Collins V. Peter,Weiss William A.,Largaespada David A.,Collier Lara S.,Taylor Michael D.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature10825.pdf

Reference28 articles.

1. Gajjar, A. et al. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet Oncol. 7, 813–820 (2006)

2. Mabbott, D. J. et al. Serial evaluation of academic and behavioral outcome after treatment with cranial radiation in childhood. J. Clin. Oncol. 23, 2256–2263 (2005)

3. MacDonald, T. J. et al. Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. Nature Genet. 29, 143–152 (2001)

4. Ramaswamy, S., Ross, K. N., Lander, E. S. & Golub, T. R. A molecular signature of metastasis in primary solid tumors. Nature Genet. 33, 49–54 (2003)

5. Goodrich, L. V., Milenkovic, L., Higgins, K. M. & Scott, M. P. Altered neural cell fates and medulloblastoma in mouse patched mutants. Science 277, 1109–1113 (1997)

Cited by 354 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intracerebellar administration of the chemokine Cxcl3 reduces the volume of medulloblastoma lesions at an advanced stage by promoting the migration and differentiation of preneoplastic precursor cells;Brain Pathology;2024-06-30

2. Triptolide and its prodrug Minnelide target high-risk MYC-amplified medulloblastoma in preclinical models;Journal of Clinical Investigation;2024-06-17

3. Drivers Underlying Metastasis and Relapse in Medulloblastoma and Targeting Strategies;Cancers;2024-04-30

4. The RNA binding proteins LARP4A and LARP4B promote sarcoma and carcinoma growth and metastasis;iScience;2024-04

5. Personalized treatment options of refractory and relapsed medulloblastoma in children: literature review;Journal of Modern Oncology;2024-02-21